Control of developmentally primed erythroid genes by combinatorial co-repressor actions

Nature Communications

Volumn 6, Issue , 2015, Pages

  Stadhouders, Ralph ^a,g   Cico, Alba ^b   Stephen, Tharshana ^b   Thongjuea, Supat ^c,d   Kolovos, Petros ^a   Baymaz, H Irem ^a   Yu, Xiao ^a   Demmers, Jeroen ^a   Bezstarosti, Karel ^a   Maas, Alex ^a   Barroca, Vilma ^b   Kockx, Christel ^a   Ozgur, Zeliha ^a   Van Ijcken, Wilfred ^a   Arcangeli, Marie Laure ^b   Andrieu Soler, Charlotte ^b   Lenhard, Boris ^e   Grosveld, Frank ^a   Soler, Eric ^a,b,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF BERGEN   (Norway)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Laboratory of Excellence GR Ex   (France)

^g CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COREPRESSOR PROTEIN; EIGHT TWENTY ONE 2 PROTEIN; GROWTH FACTOR; GROWTH FACTOR INDEPENDENT 1B; INTERFERON REGULATORY FACTOR 2 BINDING PROTEIN 2; LIM DOMAIN BINDING PROTEIN 1; LIM PROTEIN; MULTIPROTEIN COMPLEX; NUCLEAR RECEPTOR COREPRESSOR; RNA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SINGLE STRANDED DNA BINDING PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; CARRIER PROTEIN; CBFA2T3 PROTEIN, HUMAN; DNA BINDING PROTEIN; IRF2BP2 PROTEIN, HUMAN; LDB1 PROTEIN, HUMAN; NCOR1 PROTEIN, HUMAN; NCOR2 PROTEIN, HUMAN; NUCLEAR PROTEIN; RECEPTOR INTERACTING PROTEIN 140; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

BLOOD; GENE EXPRESSION; GENETIC DIFFERENTIATION; GENOMICS; PROTEIN; PROTEOMICS;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPIGENETICS; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FUNCTIONAL GENOMICS; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC ASSOCIATION; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RNA SEQUENCE; TRANSCRIPTION REGULATION; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; DNA-BINDING PROTEINS; ERYTHROID CELLS; ERYTHROPOIESIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LIM DOMAIN PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; NUCLEAR RECEPTOR CO-REPRESSOR 1; NUCLEAR RECEPTOR CO-REPRESSOR 2; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84947967189     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9893     Document Type: Article

References (70)

1. Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644 (2008).
2. Love, P. E., Warzecha, C. & Li, L. Ldb1 complexes: the new master regulators of erythroid gene transcription. Trends Genet. 30, 1-9 (2014).
3. Schuh, A. H. et al. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol. 25, 10235-10250 (2005).
4. Goardon, N. et al. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J. 25, 357-366 (2006).
5. Soler, E. et al. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 24, 277-289 (2010).
6. Li, L. et al. Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation. Blood 121, 4575-4585 (2013).
7. Meier, N. et al. Novel binding partners of Ldb1 are required for haematopoietic development. Development 133, 4913-4923 (2006).
8. Kiefer, C. M. et al. Distinct Ldb1/NLI complexes orchestrate gamma-globin repression and reactivation through ETO2 in human adult erythroid cells. Blood 118, 6200-6208 (2011).
9. Fischer, M. A., Moreno-Miralles, I., Hunt, A., Chyla, B. J. & Hiebert, S. W. Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. EMBO J. 31, 1494-1505 (2012).
10. Hunt, A., Fischer, M., Engel, M. E. & Hiebert, S. W. Mtg16/Eto2 contributes to murine T-cell development. Mol. Cell. Biol. 31, 2544-2551 (2011).
11. Chyla, B. J. et al. Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Mol. Cell. Biol. 28, 6234-6247 (2008).
12. Thiollier, C. et al. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models. J. Exp. Med. 209, 2017-2031 (2012).
13. Gruber, T. A. et al. An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell 22, 683-697 (2012).
14. Micci, F. et al. Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia. Leukemia 25, 1510-1512 (2011).
15. Barrett, C. W. et al. Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters. PLoS ONE 7, e51205 (2012).
16. Kumar, P. et al. The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration. PLoS ONE 8, e68502 (2013).
17. Enver, T. & Greaves, M. Loops, lineage, and leukemia. Cell 94, 9-12 (1998).
18. Pimkin, M. et al. Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis. Genome Res. 24, 1932-1944 (2014).
19. Gaertner, B. & Zeitlinger, J. RNA polymerase II pausing during development. Development 141, 1179-1183 (2014).
20. Wong, P. et al. Gene induction and repression during terminal erythropoiesis are mediated by distinct epigenetic changes. Blood 118, e128-e138 (2011).
21. Soler, E. et al. A systems approach to analyze transcription factors in mammalian cells. Methods 53, 151-162 (2011).
22. Hu, X. et al. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl Acad. Sci. USA 106, 10141-10146 (2009).
23. Childs, K. S. & Goodbourn, S. Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res. 31, 3016-3026 (2003).
24. Carneiro, F. R., Ramalho-Oliveira, R., Mognol, G. P. & Viola, J. P. Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. Mol. Cell. Biol. 31, 2889-2901 (2011).
25. Koeppel, M. et al. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res. 37, 322-335 (2009).
26. Yeung, K. T. et al. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Mol. Cell. Biol. 31, 2287-2298 (2011).
27. Teng, A. C. et al. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression. FASEB J. 24, 4825-4834 (2010).
28. Davis, J. N., McGhee, L. & Meyers, S. The ETO (MTG8) gene family. Gene 303, 1-10 (2003).
29. Lipkowitz, S. & Weissman, A. M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11, 629-643 (2011).
30. Amann, J. M. et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol. Cell. Biol. 21, 6470-6483 (2001).
31. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).
32. Kassouf, M. T. et al. Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells. Genome Res. 20, 1064-1083 (2010).
33. Welch, J. J. et al. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104, 3136-3147 (2004).
34. Fujiwara, T. et al. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36, 667-681 (2009).
35. Kingsley, P. D. et al. Ontogeny of erythroid gene expression. Blood 121, e5-e13 (2013).
36. ENCODE Project Consortium et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
37. Palii, C. G. et al. Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. EMBO J. 30, 494-509 (2011).
38. Sander, J. D. & Joung, J. K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347-355 (2014).
39. Testa, U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 18, 1176-1199 (2004).
40. Mottis, A., Mouchiroud, L. & Auwerx, J. Emerging roles of the corepressors NCoR1 and SMRT in homeostasis. Genes Dev. 27, 819-835 (2013).
41. Jepsen, K. et al. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102, 753-763 (2000).
42. Goodson, M. L., Mengeling, B. J., Jonas, B. A. & Privalsky, M. L. Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation. J. Biol. Chem. 286, 44988-44999 (2011).
43. Khan, N. et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. 409, 581-589 (2008).
44. Bhaskara, S. et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18, 436-447 (2010).
45. Lv, W. W., Wei, H. M., Wang, D. L., Ni, J. Q. & Sun, F. L. Depletion of histone deacetylase 3 antagonizes PI3K-mediated overgrowth of Drosophila organs through the acetylation of histone H4 at lysine 16. J. Cell Sci. 125, 5369-5378 (2012).
46. Sui, Z. et al. Tropomodulin3-null mice are embryonic lethal with anemia due to impaired erythroid terminal differentiation in the fetal liver. Blood 123, 758-767 (2014).
47. Fujiwara, T., Lee, H. Y., Sanalkumar, R. & Bresnick, E. H. Building multifunctionality into a complex containing master regulators of hematopoiesis. Proc. Natl Acad. Sci. USA 107, 20429-20434 (2010).
48. Foudi, A. et al. Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation. J. Exp. Med. 211, 909-927 (2014).
49. Saleque, S., Kim, J., Rooke, H. M. & Orkin, S. H. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol. Cell 27, 562-572 (2007).
50. Wang, J. et al. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 446, 882-887 (2007).
51. Saleque, S., Cameron, S. & Orkin, S. H. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 16, 301-306 (2002).
52. Xu, J. et al. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev. Cell 23, 796-811 (2012).
53. Tinnikov, A. A., Yeung, K. T., Das, S. & Samuels, H. H. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Res. 69, 1375-1382 (2009).
54. Stadhouders, R. et al. Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development. EMBO J. 31, 986-999 (2012).
55. Chen, H. H. et al. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis. Circ. Res. 117, 671-683 (2015).
56. Deisseroth, A. & Hendrick, D. Human alpha-globin gene expression following chromosomal dependent gene transfer into mouse erythroleukemia cells. Cell 15, 55-63 (1978).
57. van den Berg, D. L. et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6, 369-381 (2010).
58. Engelen, E. et al. Proteins that bind regulatory regions identified by histone modification chromatin immunoprecipitations and mass spectrometry. Nat. Commun. 6, 7155 (2015).
59. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
60. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
61. Xu, H. et al. A signal-noise model for significance analysis of ChIP-seq with negative control. Bioinformatics 26, 1199-1204 (2010).
62. Rozowsky, J. et al. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nat. Biotechnol. 27, 66-75 (2009).
63. Saldanha, A. J. Java Treeview-extensible visualization of microarray data. Bioinformatics 20, 3246-3248 (2004).
64. Bailey, T. L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28-36 (1994).
65. Portales-Casamar, E. et al. JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles. Nucleic Acids Res. 38, D105-D110 (2010).
66. Gupta, S., Stamatoyannopoulos, J. A., Bailey, T. L. & Noble, W. S. Quantifying similarity between motifs. Genome Biol. 8, R24 (2007).
67. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
68. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
69. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
70. Saeed, A. I. et al. TM4 microarray software suite. Methods Enzymol. 411, 134-193 (2006).